Actinogen Medical Limited (ASX:ACW)
Australia · Delayed Price · Currency is AUD 0.0450
0.00 (0.00%)
Jan 28, 2026, 4:10 PM AEST
Actinogen Medical Market Cap
Actinogen Medical has a market cap or net worth of 143.63 million as of January 29, 2026. Its market cap has increased by 83.39% in one year.
Market Cap
143.63M
Enterprise Value
130.39M
Revenue
5.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.05
Market Cap Chart
Since October 16, 2007, Actinogen Medical's market cap has increased from 12.97M to 143.63M, an increase of 1,007.19%. That is a compound annual growth rate of 14.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 143.63M | -26.12% |
| Dec 31, 2025 | 194.40M | 148.21% |
| Dec 31, 2024 | 78.32M | 54.29% |
| Dec 29, 2023 | 50.76M | -71.90% |
| Dec 30, 2022 | 180.63M | -36.39% |
| Dec 31, 2021 | 283.98M | 832.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orthocell | 260.46M |
| Botanix Pharmaceuticals | 226.56M |
| Tetratherix | 194.43M |
| Recce Pharmaceuticals | 189.42M |
| Starpharma Holdings | 146.97M |
| Paradigm Biopharmaceuticals | 138.71M |
| Proteomics International Laboratories | 118.87M |
| Imugene | 113.52M |